News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
272,464 Results
Type
Article (14181)
Company Profile (109)
Press Release (258171)
Multimedia
Podcasts (63)
Webinars (13)
Section
Business (88258)
Career Advice (466)
Deals (15383)
Drug Delivery (70)
Drug Development (36694)
Employer Resources (50)
FDA (6363)
Job Trends (6228)
News (150644)
Policy (14120)
Tag
Academia (441)
Accelerated approval (9)
Adcomms (7)
Allergies (60)
Alliances (23319)
ALS (52)
Alzheimer's disease (465)
Antibody-drug conjugate (ADC) (90)
Approvals (6507)
Artificial intelligence (182)
Autoimmune disease (27)
Automation (9)
Bankruptcy (150)
Best Places to Work (4371)
BIOSECURE Act (9)
Biosimilars (104)
Biotechnology (40)
Bladder cancer (36)
Brain cancer (27)
Breast cancer (143)
Cancer (1169)
Cardiovascular disease (136)
Career advice (416)
Career pathing (13)
CAR-T (41)
CDC (6)
Cell therapy (133)
Cervical cancer (8)
Clinical research (31808)
Collaboration (613)
Compensation (301)
Complete response letters (30)
COVID-19 (776)
CRISPR (39)
C-suite (359)
Cystic fibrosis (55)
Data (1604)
Denatured (18)
Depression (33)
Diabetes (120)
Diagnostics (1369)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (99)
Drug pricing (107)
Drug shortages (12)
Duchenne muscular dystrophy (74)
Earnings (33367)
Editorial (18)
Employer branding (4)
Employer resources (45)
Events (38749)
Executive appointments (519)
FDA (7341)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (385)
Gene editing (63)
Generative AI (15)
Gene therapy (153)
GLP-1 (423)
Government (1388)
Grass and pollen (4)
Guidances (161)
Healthcare (3576)
HIV (9)
Huntington's disease (7)
IgA nephropathy (35)
Immunology and inflammation (61)
Immuno-oncology (6)
Indications (37)
Infectious disease (834)
Inflammatory bowel disease (69)
Inflation Reduction Act (7)
Influenza (21)
Intellectual property (97)
Interviews (60)
IPO (5910)
IRA (33)
Job creations (2055)
Job search strategy (374)
Kidney cancer (9)
Labor market (27)
Layoffs (204)
Leadership (8)
Legal (3448)
Liver cancer (21)
Longevity (7)
Lung cancer (172)
Lymphoma (105)
Machine learning (12)
Management (17)
Manufacturing (346)
MASH (64)
Medical device (1298)
Medtech (1301)
Mergers & acquisitions (9845)
Metabolic disorders (395)
Multiple sclerosis (40)
NASH (14)
Neurodegenerative disease (72)
Neuropsychiatric disorders (25)
Neuroscience (815)
NextGen: Class of 2025 (1590)
Non-profit (599)
Now hiring (16)
Obesity (201)
Opinion (138)
Ovarian cancer (34)
Pain (103)
Pancreatic cancer (43)
Parkinson's disease (70)
Partnered (9)
Patents (201)
Patient recruitment (98)
Peanut (12)
People (29603)
Pharmaceutical (63)
Pharmacy benefit managers (16)
Phase I (8249)
Phase II (13430)
Phase III (12126)
Pipeline (1367)
Policy (125)
Postmarket research (1402)
Preclinical (3326)
Press Release (25)
Prostate cancer (78)
Psychedelics (14)
Radiopharmaceuticals (126)
Rare diseases (290)
Real estate (2655)
Recruiting (18)
Regulatory (10752)
Reports (15)
Research institute (572)
Resumes & cover letters (55)
Rett syndrome (3)
RNA editing (5)
RSV (18)
Schizophrenia (61)
Series A (70)
Series B (42)
Service/supplier (3)
Sickle cell disease (43)
Special edition (10)
Spinal muscular atrophy (78)
Sponsored (8)
Startups (1643)
State (2)
Stomach cancer (4)
Supply chain (43)
Tariffs (67)
The Weekly (43)
Vaccines (220)
Venture capital (27)
Weight loss (129)
Women's health (20)
Worklife (4)
Date
Last 7 days (195)
Last 30 days (898)
Last 365 days (10809)
2025 (10268)
2024 (12526)
2023 (14255)
2022 (19566)
2021 (20074)
2020 (19035)
2019 (14885)
2018 (11713)
2017 (13889)
2016 (13130)
2015 (15472)
2014 (12420)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (318)
Alabama (17)
Alaska (1)
Arizona (72)
Arkansas (3)
Asia (20714)
Australia (2665)
California (2929)
Canada (1388)
China (470)
Colorado (126)
Connecticut (121)
Delaware (116)
Europe (40606)
Florida (560)
Georgia (59)
Hawaii (1)
Idaho (10)
Illinois (313)
India (37)
Indiana (219)
Iowa (1)
Japan (202)
Kansas (75)
Kentucky (19)
Louisiana (3)
Maine (2)
Maryland (402)
Massachusetts (2416)
Michigan (42)
Minnesota (150)
Mississippi (1)
Missouri (32)
Montana (8)
Nebraska (6)
Nevada (16)
New Hampshire (6)
New Jersey (1315)
New Mexico (7)
New York (831)
North Carolina (571)
North Dakota (2)
Northern California (1310)
Ohio (71)
Oklahoma (5)
Oregon (17)
Pennsylvania (669)
Puerto Rico (10)
Rhode Island (15)
South America (505)
South Carolina (9)
Southern California (1270)
Tennessee (50)
Texas (408)
United States (11773)
Utah (56)
Virginia (146)
Washington D.C. (41)
Washington State (200)
West Virginia (1)
Wisconsin (31)
Wyoming (1)
272,464 Results for "pacira pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 3, 2025
December 3, 2025
·
1 min read
Press Releases
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences - November 11, 2025
November 12, 2025
·
1 min read
Press Releases
Pacira to Report Third Quarter 2025 Financial Results on Thursday November 6, 2025
October 31, 2025
·
1 min read
Press Releases
Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL®
October 24, 2025
·
9 min read
Press Releases
Pacira BioSciences Reports Third Quarter 2025 Financial Results; Increases Full-year Gross Margin Guidance
November 6, 2025
·
38 min read
Press Releases
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
October 22, 2025
·
8 min read
Press Releases
Pacira BioSciences Enters Exclusive License Agreement with AmacaThera for its Novel Long-acting Analgesic for Postsurgical Pain Control
November 5, 2025
·
7 min read
Press Releases
Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain
December 3, 2025
·
9 min read
Press Releases
Pacira BioSciences Concludes Patient Enrollment in Part A of Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee
November 6, 2025
·
10 min read
Press Releases
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 3, 2025
October 6, 2025
·
2 min read
1 of 27,247
Next
